Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series
176931769317693
In this brief communication, JDD authors T. Roxana Ghadimi BS, Michael J. Martinez BS, and Evan A. Rieder MD present self-reported long-term, remote side effects to isotretinoin that dermatologists must be aware of.
INTRODUCTION
Isotretinoin is considered the gold standard treatment for severe nodulocystic acne, though it has been the subject of controversy in the media for concerns relate …
In this brief communication, JDD authors T. Roxana Ghadimi BS, Michael J. Martinez BS, and Evan A. Rieder MD present self-reported long-term, remote side effects to isotretinoin that dermatologists must be aware of.
INTRODUCTION
Isotretinoin is considered the gold standard treatment for severe nodulocystic acne, though it has been the subject of controversy in the media for concerns relate … Continue reading "Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series"
The June issue of the Journal of Drugs in Dermatology (JDD) features original articles with topics ranging from pediatric acne, rosacea, androgenetic alopecia, precision medicine, infantile hemangiomas, and many more. Check out this month’s issue highlights straight from the JDD Editor’s desk:
The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and … 
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several … 
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition.1 Due to its longer duration of action, it is typically administered subcutaneously once weekly. The safety profile of semaglutide is similar to … 
The May issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and includes the perfect blend of original articles and case reports. Topics include actinic keratosis versus squamous cell carcinoma, the utility of gene expression profiling in skin cancer, the prevalence of sunscreen use, and many more. Check out this month’s issue highlights straight from the JDD Editor’s … 